相似文献
1
[Reactivation in immunosuppression. Complicated hepatitis comeback].
MMW Fortschr Med. 2004 Sep 23;146(39):5-6.
2
Infection in solid-organ transplant recipients.
N Engl J Med. 2007 Dec 20;357(25):2601-14. doi: 10.1056/NEJMra064928.
3
Strategy of cytomegalovirus infection prevention in renal transplantation.
Adv Nephrol Necker Hosp. 1994;23:331-45.
4
Direct and indirect effects of cytomegalovirus: can we prevent them?
Enferm Infecc Microbiol Clin. 2010 Jan;28(1):1-5. doi: 10.1016/j.eimc.2009.07.008. Epub 2009 Dec 21.
5
Infectious complications of immunosuppressive medications in organ transplant recipients.
Pediatr Infect Dis J. 2007 May;26(5):443-4. doi: 10.1097/01.inf.0000261010.28610.88.
6
[Clinical analysis of infectious complications following abdominal cluster transplantation].
Zhonghua Wai Ke Za Zhi. 2007 Mar 1;45(5):319-22.
7
[Ocular symptoms in cytomegalovirus infection].
Klin Oczna. 1988 Nov;90(11):391-2.
8
Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
Am J Hematol. 2005 Nov;80(3):197-203. doi: 10.1002/ajh.20471.
9
[Chemotherapy and immunosuppression in patients with hepatitis B or C].
Gastroenterol Clin Biol. 2001 Nov;25(11):1002-7.
10
Annual literature review--clinical transplants 2000.
Clin Transpl. 2000:411-65.
Zotero 插件